KX Modifier in Medical Billing: Experimental/Investigational Services

Definition

The KX modifier is appended to a CPT/HCPCS code to indicate that a service or item is experimental or investigational—not FDA-approved for the specific indication, but provided under a clinical trial, compassionate use, or with specific payer approval.

When to Use

  • Medicare requires KX for certain Category III CPT codes (emerging technologies).
  • Some private payers require it for off-label or investigational use.
  • Documentation must support medical necessity and IRB/IDE status if applicable.

Important Notes

  • KX does not guarantee payment; it flags the service for review.
  • Pair with appropriate diagnosis codes (e.g., Z00.6 for clinical trial).
  • Distinct from GZ (item/service expected to be denied as not reasonable/necessary) and GA (waiver of liability on file).

Medical Billing - Related Articles